Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection | Clostridium Difficile Infection Recurrence | Recruiting | Phase 2 | 2026-08-12 | NCT07513285 |